The global pharmaceutical supply chain is at growing risk from counterfeit drugs, costing companies billions and putting the health of patients in danger.

The World Health Organization (WHO) currently estimates the global trade in counterfeit drugs to be worth £75 billion and expects continued growth at an alarming rate of 13% a year. The WHO has also suggested that 1% of prescribed drugs in the developed world and 30% in parts of the developing world may be fake. The threat is even bigger on the internet, 50% of drugs bought on illegal online pharmacies are thought to be counterfeits. As the counterfeit trade grows and becomes more profitable the criminals are becoming increasingly sophisticated and capable in the ways they operate.

To combat these issues, pharmaceutical companies need to employ a multi-level approach to beat the counterfeiters. Payne Security’s experience in combining overt, covert and forensic security technologies offers pharmaceutical companies a robust way of protecting their products from counterfeiting.

In addition to this, to combat diversion, Payne Security offers a range of mass serialisation and track & trace technologies, from numbering or barcodes through to FractureCode®, that integrate as part of a multi-level brand protection solution. Options include:

• Unique number marking (sequential or non-sequential)
• Barcodes - linear, 2D data matrix, QR codes
• FractureCode®

For a confidential discussion on how Payne Security can integrate track & trace technology within our multi-level brand protection solutions, please contact us or email sales@payne-security.com